184 related articles for article (PubMed ID: 33180744)
1. Caspase-3 knockout attenuates radiation-induced tumor repopulation via impairing the ATM/p53/Cox-2/PGE
Zhao M; Wang Y; Zhao Y; He S; Zhao R; Song Y; Cheng J; Gong Y; Xie J; Wang Y; Hu B; Tian L; Huang Q
Aging (Albany NY); 2020 Nov; 12(21):21758-21776. PubMed ID: 33180744
[TBL] [Abstract][Full Text] [Related]
2. CB11, a novel purine-based PPARɣ ligand, overcomes radio-resistance by regulating ATM signalling and EMT in human non-small-cell lung cancer cells.
Kim TW; Hong DW; Park JW; Hong SH
Br J Cancer; 2020 Dec; 123(12):1737-1748. PubMed ID: 32958825
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of the DNA damage response by transforming growth factor-beta inhibitors enhances radiation sensitivity of non-small-cell lung cancer cells in vitro and in vivo.
Du S; Bouquet S; Lo CH; Pellicciotta I; Bolourchi S; Parry R; Barcellos-Hoff MH
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):91-9. PubMed ID: 25835621
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK.
Storozhuk Y; Hopmans SN; Sanli T; Barron C; Tsiani E; Cutz JC; Pond G; Wright J; Singh G; Tsakiridis T
Br J Cancer; 2013 May; 108(10):2021-32. PubMed ID: 23632475
[TBL] [Abstract][Full Text] [Related]
5. The p53-53BP1-Related Survival of A549 and H1299 Human Lung Cancer Cells after Multifractionated Radiotherapy Demonstrated Different Response to Additional Acute X-ray Exposure.
Pustovalova M; Alhaddad L; Smetanina N; Chigasova A; Blokhina T; Chuprov-Netochin R; Osipov AN; Leonov S
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397297
[TBL] [Abstract][Full Text] [Related]
6. The Caspase-3/PKCδ/Akt/VEGF-A Signaling Pathway Mediates Tumor Repopulation during Radiotherapy.
Cheng J; He S; Wang M; Zhou L; Zhang Z; Feng X; Yu Y; Ma J; Dai C; Zhang S; Sun L; Gong Y; Wang Y; Zhao M; Luo Y; Liu X; Tian L; Li C; Huang Q
Clin Cancer Res; 2019 Jun; 25(12):3732-3743. PubMed ID: 30890550
[TBL] [Abstract][Full Text] [Related]
7. An anthraquinone derivative from Luffa acutangula induces apoptosis in human lung cancer cell line NCI-H460 through p53-dependent pathway.
Vanajothi R; Srinivasan P
J Recept Signal Transduct Res; 2016; 36(3):292-302. PubMed ID: 26585176
[TBL] [Abstract][Full Text] [Related]
8. NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling.
Jin X; Liu X; Zhang Z; Xu L
Biochem Biophys Res Commun; 2020 Dec; 533(3):354-361. PubMed ID: 32962856
[TBL] [Abstract][Full Text] [Related]
9. hnRNPA2/B1 activates cyclooxygenase-2 and promotes tumor growth in human lung cancers.
Xuan Y; Wang J; Ban L; Lu JJ; Yi C; Li Z; Yu W; Li M; Xu T; Yang W; Tang Z; Tang R; Xiao X; Meng S; Chen Y; Liu Q; Huang W; Guo W; Cui X; Deng W
Mol Oncol; 2016 Apr; 10(4):610-24. PubMed ID: 26774881
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells.
Kang J; Kim W; Kwon T; Youn H; Kim JS; Youn B
Oncotarget; 2016 Apr; 7(17):23961-74. PubMed ID: 27004408
[TBL] [Abstract][Full Text] [Related]
11. Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE
Che D; Zhang S; Jing Z; Shang L; Jin S; Liu F; Shen J; Li Y; Hu J; Meng Q; Yu Y
Mol Immunol; 2017 Oct; 90():197-210. PubMed ID: 28837884
[TBL] [Abstract][Full Text] [Related]
12. Nimesulide, a selective COX-2 inhibitor, acts synergistically with ionizing radiation against A549 human lung cancer cells through the activation of caspase-8 and caspase-3.
Kim BM; Won J; Maeng KA; Han YS; Yun YS; Hong SH
Int J Oncol; 2009 May; 34(5):1467-73. PubMed ID: 19360361
[TBL] [Abstract][Full Text] [Related]
13. The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status.
Pustovalova M; Alhaddad L; Blokhina T; Smetanina N; Chigasova A; Chuprov-Netochin R; Eremin P; Gilmutdinova I; Osipov AN; Leonov S
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673439
[TBL] [Abstract][Full Text] [Related]
14. cAMP signaling inhibits radiation-induced ATM phosphorylation leading to the augmentation of apoptosis in human lung cancer cells.
Cho EA; Kim EJ; Kwak SJ; Juhnn YS
Mol Cancer; 2014 Feb; 13():36. PubMed ID: 24568192
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin L activated by mutant p53 and Egr-1 promotes ionizing radiation-induced EMT in human NSCLC.
Wang W; Xiong Y; Ding X; Wang L; Zhao Y; Fei Y; Zhu Y; Shen X; Tan C; Liang Z
J Exp Clin Cancer Res; 2019 Feb; 38(1):61. PubMed ID: 30732622
[TBL] [Abstract][Full Text] [Related]
16. Dying glioma cells establish a proangiogenic microenvironment through a caspase 3 dependent mechanism.
Feng X; Yu Y; He S; Cheng J; Gong Y; Zhang Z; Yang X; Xu B; Liu X; Li CY; Tian L; Huang Q
Cancer Lett; 2017 Jan; 385():12-20. PubMed ID: 27826040
[TBL] [Abstract][Full Text] [Related]
17. DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue.
Jäämaa S; Af Hällström TM; Sankila A; Rantanen V; Koistinen H; Stenman UH; Zhang Z; Yang Z; De Marzo AM; Taari K; Ruutu M; Andersson LC; Laiho M
Cancer Res; 2010 Nov; 70(21):8630-41. PubMed ID: 20978201
[TBL] [Abstract][Full Text] [Related]
18. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
19. Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.
Xie H; Li C; Dang Q; Chang LS; Li L
Oncotarget; 2016 Jan; 7(2):1341-53. PubMed ID: 26625310
[TBL] [Abstract][Full Text] [Related]
20. TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer.
Tesei A; Arienti C; Bossi G; Santi S; De Santis I; Bevilacqua A; Zanoni M; Pignatta S; Cortesi M; Zamagni A; Storci G; Bonafè M; Sarnelli A; Romeo A; Cavallo C; Bartolazzi A; Rossi S; Soriani A; Strigari L
J Exp Clin Cancer Res; 2021 Mar; 40(1):89. PubMed ID: 33673859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
